Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Superior Alternative to Pads and Tampons More
Currently, LTS has two matrix formulation under development varying in their manufacturing process More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Patent pending prebiotic suppositories deliver prebiotics directly to the vagina, supporting growth of protective vaginal flora and discouraging overgrowth of pathogenic bacteria and yeast More
Nestorone® MDTS®: New Generation Contraceptive for Delivery by Acrux's Unique Spray Technology More
Towards the Clinical Development of Bio-T Gel: A Once Daily Transdermal Gel to Treat Male Hypogonadism More
Acrux Advances Clinical Development of Investigational Testosterone Spray for Women: Testosterone MDTS® for the Treatment of Female Androgen Insufficiency More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 124 pages - $1,495
Nov 2010 - 178 pages - $1,495
Dec 2010 - 7 pages - $15,200
Jan 2011 - 124 pages - $1,740
Jul 2011 - 296 pages - $500
Jan 2011 - 23 pages - $500
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Sep 2011 - 65 pages - $500
Nov 2010 - 428 pages - $2,695
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us